Deal Library / Pharma BD Deal Intelligence

Celgene Corporation — Pharma Deals

The Pharma Closeout tracks 13 deals, $36.8B in disclosed deal value, 10 with a post-close Outcome Score for Celgene Corporation.

Median Critic Score: 84 · Median Outcome Score: 58

All 13 deals

Celgene Corporation / Juno Therapeutics Inc. — 2015 · $2.0B · Worked — the deal delivered on its rationale.
Celgene Corporation / Agios Pharmaceuticals Inc. — 2010 · $130M · Worked — the deal delivered on its rationale.
Celgene Corporation / Juno Therapeutics Inc. — 2018 · $9.0B · Largely worked — most objectives met.
Celgene Corporation / Abraxis BioScience Inc. — 2010 · $2.9B · Largely worked — most objectives met.
Celgene Corporation / Receptos Inc. — 2015 · $7.2B · Largely worked — most objectives met.
Celgene Corporation / Impact Biomedicines — 2018 · $7.0B · Mixed — partial payoff, real shortfalls.
Celgene Corporation / Gloucester Pharmaceuticals, Inc. — 2009 · $640M · Underwhelmed — fell short of the thesis.
Celgene Corporation / Jounce Therapeutics Inc. — 2016 · $2.7B · Did not work — the deal failed to deliver.
Celgene Corporation / Avila Therapeutics, Inc. — 2012 · $925M · Did not work — the deal failed to deliver.
Celgene Corporation / OncoMed Pharmaceuticals Inc. — 2013 · $3.3B · Did not work — the deal failed to deliver.
Celgene Corporation / Sutro Biopharma, Inc. — 2014 · $185M
Celgene Corporation / Forma Therapeutics Holdings, LLC — 2014 · $600M
Celgene Corporation / Forma Therapeutics Holdings LLC — 2013 · $200M